Preview complete
The prescreener preview is complete. You may now close the preview.
Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITY
Detailed Description
This is an online research study to learn more about how genes affect the risk of kidney disease. This is an online research study to learn more about how genes affect the risk of kidney disease. No office visit is required and in return, participants may receive information about their genetic ancestry for free. One in seven individuals in the United States today has chronic kidney disease (CDC 2023). The heritability -a measure of genetic, as opposed to environmental, contribution to a disease- of kidney function such as the estimated glomerular filtration rate (eGFR) has been estimated at 38%This study will increase our understanding of the genetic basis of kidney disease, which is a crucial step in drug development to improve current treatment options. The study investigators seek a diverse population because diversity among participants maximizes the usefulness of the data. Participants will use our online study portal to answer questions about their health and provide their DNA via a saliva sample using a pre-paid mailer. Participation takes approximately 20 minutes. Participants will be invited to share data from their electronic health records, but this is not required for study participation. The study investigators keep participants engaged with short monthly newsletters.
Simple Text Block
You can use content blocks to arrange your articles, large texts,
instructions. Combine these blocks with media blocks to add
illustrations and video tutorials. You can use various content blocks to
work with your text. Add quotations, lists, buttons. Select your text to
change its formatting or add links. You can use various content blocks
to work with your text. Add quotations, lists, buttons. Select your text
to change its formatting or add links.
Call 1800-9860-568 now to find out if you are eligible.
Check your eligibility
Take up this questionnaire to help us determine if you have symptoms
that are common to this clinical study. If you have the common
symptoms, you may be eligible to take part in the study.
Age
18 - None
Gender
All
NCT ID
NCT07217535
Phase
-1
Status
Recruiting Now
Medical Condition
Nephropathy
How is Plaque Psoriasis treated?
Medical Condition
A short sentence to introduce what to expect in the about condition
section
Learn moreThe Study
A short sentence to introduce what to expect in the about condition
section
Learn moreAbout Clinical Trials
A short sentence to introduce what to expect in the about condition
section
Learn moreYour Journey
01
Receiving the medication
You would receive etanercept (Enbrel) twice a week for 12 weeks and
then once a week for 12 weeks. Etanercept, as well as study related
medical care, is provided at no cost.
02
Visiting the study site
Study participation involves approximately 8 visits to your local
study center over 6 to 7 months.
03
Follow-up
There would also be a follow-up telephone call 30days after
completing the study. No visits are required after participation is
complete.